Endoscopic Retrograde Cholangiopancreatography Patient Registry
Methodist Health System
Summary
The risk of post-endoscopic retrograde cholangiopancreatography(ERCP) pancreatitis(PEP) is influenced by patient and procedure-related factors. Strategies to decrease PEP(Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis) are of great importance.
Description
The primary objective of this study is to provide a mechanism to store the following information about patients undergoing ERCPs at Methodist Dallas Medical Center. This registry will be permissive of quality improvement and research studies.
Eligibility
- Age range
- 15+ years
- Sex
- All
- Healthy volunteers
- No
Inclusion Criteria: Patients \>15 years Included in MDI's Registry Underwent ERCP between January 1, 2000 through December 31, 2025 Exclusion Criteria: Patients \<15 years Patients in which cannulation was via a surgical anastomosis Patients in which cannulation was not attempted due to gastric outlet obstruction, the main papilla not found, or the minor papilla was not found will be excluded.
Interventions
- OtherPatients undergoing ERCPs at Methodist Dallas Medical Center
The registry will include all patients who meet registry inclusion. Enrollment will terminate once 25 years of data are captured: January 1, 2000 through December 31, 2025.
Location
- Methodist Dallas Medical Center- Clinical Research InstituteDallas, Texas